glp-1 digital health news Novo Nordisk seeks partners to boost GLP-1RA weight loss outcomes As more Americans turn to

"Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome"

Funding This research was supported by grants from the National Institutes of Health [K23DK127157-01 ELB]

Tirzepatide represents a dual agonist, activating both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, which may explain its particularly robust weight loss effects

Immunity to Tuberculosis

But doctors may need to consider recommending exercise programs or develop other approaches, such as nutrition supplements or complementary medications, to help GLP-1 patients get the full cardiorespiratory benefits of substantial weight loss over the long-run, the researchers say